Reaction
Congenital Genital Malformation reporting signals
As of the last recalculation, Congenital Genital Malformation appears in 160 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is RALTEGRAVIR (PRR 302.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Raltegravir | 31 | 302.7 | 303.3 |
| Zidovudine | 25 | 288.1 | 288.6 |
| Darunavir | 26 | 266.8 | 267.3 |
| Ritonavir | 27 | 144.4 | 144.5 |
| Valproate Sodium | 17 | 119.6 | 119.7 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 27 | 92.4 | 92.5 |